Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAHALO: Lampalizumab in Geographic Atrophy
NCT01229215Phase 2Completed
- Sponsor
- Genentech
- Start
- Feb 2011
- Primary completion
- Apr 2013
- Modality
- Antibody Fragments
- Countries
- 2
01
Overview
A Phase 2 trial of lampalizumab in geographic atrophy (GA), sponsored by Genentech. Started Feb 2011; status: completed.
02
Drugs
lampalizumab
03
Conditions
geographic atrophy (GA)
Beyond the preview
Go deeper on NCT01229215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01229215.